Please login to the form below
Infographic: Orphan drug market
A visual guide to the orphan drug and rare disease market for pharma
This infographic provides some key details about the orphan drug market for the pharma industry.
For a more detailed look at market access for orphan drugs read 'Orphan indication? No easy access'.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
-
Senior Account Manager
-
Salary TBC
-
Publications Director
-
Competitive Salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
-
Planner
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Piloting a route to the biosimilars opportunities in Europe
- FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
- Diversity and inclusion in clinical trials
- Live Webinar: Realizing the Potential of Genomics-Driven Precision Medicine
- Novartis’ iptacopan scores positive results in rare blood disorder PNH
- Sanofi’s C1s inhibitor sutimlimab hits the mark in late-stage CAD study
- bluebird bio presents new data for beti-cel in beta thalassemia at EHA2021
- Roche reveals four-year follow-up data for Venclyxto in CLL at EHA2021
- First NHS patient treated with Novartis’ SMA gene therapy Zolgensma
- FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Novo Nordisk says Victoza outperforms SGLT2 inhibitors
- FDA advisory committee overwhelmingly votes no on Biogen's aducanumab
- Pfizer CEO says oral COVID-19 pill could be ready by the end of the year
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
